Skip to main content
. 2022 Jan 1;18(1):199–213. doi: 10.7150/ijbs.65402

Figure 8.

Figure 8

Schematic representation of RIP3 blockade in preventing immune-mediated hepatitis. RIP3 kinase inhibition promotes the hepatic accumulation of MDSCs by CXCL1-CXCR2 axis and other unknown factors. Accumulated MDSCs mediate the hepatoprotective effect of GSK872 by reducing the frequencies of Th17 cells and macrophages but increasing those of Treg cells.